ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,277.51
0.80%
US Tech 100
18,064.80
0.02%
다우존스 지수
38,686.32
1.51%
Bitcoin
67,705.34
0.33%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Point Therapeutics (MM) (POTP)

  7. Point Therapeutics (MM) (POTP) 뉴스

POTP

Point Therapeutics (MM) (POTP)

Point Therapeutics (MM)
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:POTP
일자시간출처헤드라인심볼기업
2008/02/1306:15PR Newswire (US)DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of MergerNASDAQ:POTPPoint Therapeutics (MM)
2008/02/1305:02Edgar (US Regulatory)Point Therapeutics Inc - Amended Statement of Ownership (SC 13G/A)NASDAQ:POTPPoint Therapeutics (MM)
2008/02/1204:30Edgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
2008/02/1123:00Business WireUpdate on Point Therapeutics Merger with DARA BioSciencesNASDAQ:POTPPoint Therapeutics (MM)
2008/02/0900:23Edgar (US Regulatory)Point Therapeutics Inc-Filing of certain prospectuses & communications for business combination transactions (425)NASDAQ:POTPPoint Therapeutics (MM)
2008/02/0422:36Edgar (US Regulatory)Point Therapeutics Inc-Filing of certain prospectuses & communications for business combination transactions (425)NASDAQ:POTPPoint Therapeutics (MM)
2008/02/0421:30PR Newswire (US)DARA BioSciences to Present at the ROTH Growth Stock ConferenceNASDAQ:POTPPoint Therapeutics (MM)
2008/01/3006:30Business WirePoint Therapeutics Adjourns Meeting of Stockholders to February 12, 2008; DARA BioSciences Stockholders Approve Merger with PoinNASDAQ:POTPPoint Therapeutics (MM)
2008/01/1720:03Edgar (US Regulatory)Point Therapeutics Inc-Filing of certain prospectuses & communications for business combination transactions (425)NASDAQ:POTPPoint Therapeutics (MM)
2008/01/1104:07Edgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
2008/01/1022:00Business WirePoint Therapeutics Receives Additional Notice of Non-Compliance from NASDAQNASDAQ:POTPPoint Therapeutics (MM)
2007/12/2805:45Edgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
2007/12/2805:43Edgar (US Regulatory)Point Therapeutics Inc-Filing of certain prospectuses & communications for business combination transactions (425)NASDAQ:POTPPoint Therapeutics (MM)
2007/12/2722:30Business WirePoint Therapeutics Announces Form S-4 Registration Statement Declared Effective by SEC; Special Meeting of Stockholders Set forNASDAQ:POTPPoint Therapeutics (MM)
2007/12/1902:55Edgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
2007/12/1807:12Edgar (US Regulatory)Point Therapeutics Inc - Registration Statement for securities to be issued in business combination transactions (S-4/A)NASDAQ:POTPPoint Therapeutics (MM)
2007/12/1803:17Edgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
2007/12/1722:30Business WireNASDAQ Panel Grants Request of Point Therapeutics for Continued Listing on NASDAQ Capital MarketNASDAQ:POTPPoint Therapeutics (MM)
2007/11/2621:13Edgar (US Regulatory)Point Therapeutics Inc - Securities Registration: Business Combination (S-4)NASDAQ:POTPPoint Therapeutics (MM)
2007/11/2002:36Edgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
2007/11/0923:59Edgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
2007/11/0923:38Edgar (US Regulatory)Point Therapeutics Inc - Quarterly Report (10-Q)NASDAQ:POTPPoint Therapeutics (MM)
2007/10/2520:00PR Newswire (US)DARA BioSciences, Inc. Announces New Board ChairmanNASDAQ:POTPPoint Therapeutics (MM)
2007/10/1720:00PR Newswire (US)DARA BioSciences and Bayer Pharmaceuticals Corporation Sign Exclusive License AgreementNASDAQ:POTPPoint Therapeutics (MM)
2007/09/1904:36Edgar (US Regulatory)Point Therapeutics Inc - Current report filing (8-K)NASDAQ:POTPPoint Therapeutics (MM)
2007/08/1005:01Business WirePoint Therapeutics Reports Second Quarter 2007 Financial ResultsNASDAQ:POTPPoint Therapeutics (MM)
2007/07/2720:30Business WirePoint Therapeutics Announces Further Management ReductionsNASDAQ:POTPPoint Therapeutics (MM)
2007/07/1221:30Business WirePoint Therapeutics UpdateNASDAQ:POTPPoint Therapeutics (MM)
2007/05/3121:00Business WirePoint Therapeutics Reduces Costs by Cutting Work ForceNASDAQ:POTPPoint Therapeutics (MM)
2007/05/2121:00Business WireTalabostat Clinical Program Put on Clinical Hold by FDANASDAQ:POTPPoint Therapeutics (MM)
 검색 관련기사 보기:NASDAQ:POTP

최근 히스토리

BIT
UC3XAG
Unicredit Bank
USOTC
HRSEF
Hirose Electric (PK)
ASX
GSIO35
Commonwealth of Australia
LSE
60BJ
Sg Issuer 26
BIT
UC4ST8
Unicredit Bank
TSXV
ISF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유